Connor, Clark & Lunn Investment Management Ltd. Inotiv, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$3.27 - $11.04 $68,293 - $230,570	20,885 New	20,885 $228,000
Q1 2022 May 12, 2022	SELL	$18.52 - $40.41 $317,358 - $692,465	-17,136 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$30.55 - $57.88 $115,692 - $219,191	3,787 Added 28.37%	17,136 $721,000
Q3 2021 Nov 12, 2021	BUY	$23.69 - $49.93 $316,237 - $666,515	13,349 New	13,349 $390,000

Others Institutions Holding NOTV

# of Institutions

Shares Held

3.67M

Call Options Held

1.1K

Put Options Held

21.3K

Vanguard Group Inc Valley Forge, PA

1.05M
Shares

$5 Million
0.0% of portfolio
Ameriprise Financial Inc Minneapolis, MN

268K
Shares

$1.27 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

251K
Shares

$1.19 Million
0.0% of portfolio
Kpp Advisory Services LLC Louisville, KY

238K
Shares

$1.13 Million
0.1% of portfolio
Black Rock Inc. New York, NY

213K
Shares

$1.01 Million
0.0% of portfolio

View Full List

About Inotiv, Inc.

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $122M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

More about NOTV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account